Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Goodwin

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cancer|September 1, 1996
A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group studyL Elias, B A Blumenstein, J Kish, et al.
Journal of the National Cancer Institute|June 3, 1992
Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trialL E Flaherty, P Y Liu, W S Fletcher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group studyG Weiss, S Green, D S Alberts, et al.
American Journal of Clinical Oncology|April 1, 1996
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921)L E Flaherty, P Y Liu, M S Mitchell, et al.
The Prostate|March 10, 2001
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)K J Pienta, E I Fisher, M A Eisenberger, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229)C R Thomas, D J Giroux, K J Stelzer, et al.
The Cancer Journal From Scientific American|August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trialP J Hesketh, J J Crowley, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology GroupN Murray, R B Livingston, F A Shepherd, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cancer|September 1, 1996
A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma. A Southwest Oncology Group studyL Elias, B A Blumenstein, J Kish, et al.
Journal of the National Cancer Institute|June 3, 1992
Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trialL E Flaherty, P Y Liu, W S Fletcher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group studyG Weiss, S Green, D S Alberts, et al.
American Journal of Clinical Oncology|April 1, 1996
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921)L E Flaherty, P Y Liu, M S Mitchell, et al.
The Prostate|March 10, 2001
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)K J Pienta, E I Fisher, M A Eisenberger, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229)C R Thomas, D J Giroux, K J Stelzer, et al.
The Cancer Journal From Scientific American|August 10, 1999
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trialP J Hesketh, J J Crowley, H A Burris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology GroupN Murray, R B Livingston, F A Shepherd, et al.
Pageof 4